SCHEMBL7457741

SCHEMBL7457741

NC(=O)C(=O)NCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 2/20 0.52
LDHA P00338 2/20 0.42
LDHB P07195 1/20 0.42
PLA2G2A P14555 1/20 0.42
MAPT P10636 2/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
PTGS2 P35354 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HIF1A Q16665 1/20 0.39
SLC22A6 Q4U2R8 1/20 0.39
SLC22A8 Q8TCC7 1/20 0.39
TGFBR1 P36897 1/20 0.38
CTH P32929 1/20 0.37
MME P08473 2/20 0.36
APEX1 P27695 1/20 0.35
SRR Q9GZT4 1/20 0.35
ECE1 P42892 1/20 0.34
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11300324 0.82
SCHEMBL9999987 0.82 EGLN1 (0.62) EGLN1LDHAPLA2G2AMAPTALDH1A1
SCHEMBL8404884 0.80 EGLN1 (0.50) EGLN1LDHALDHBPLA2G2AMAPT
SCHEMBL8842594 0.80 TGFBR1 (0.34) EGLN1LDHALDHBALDH1A1LMNA
SCHEMBL17075711 0.77 PLA2G2A (0.47) EGLN1LDHALDHBPLA2G2AMAPT
Hydrogen Peroxide SCHEMBL8356290 0.77 EGLN1 (0.44) EGLN1LDHALDHBPLA2G2AMAPT
N-Oxalylglycine SCHEMBL435820 0.77 EGLN1 (0.56) EGLN1LDHAPLA2G2AMAPTALDH1A1
SCHEMBL1765080 0.77 EGLN1 (0.44) EGLN1LDHALDHBPLA2G2AMAPT
SCHEMBL289921 0.77
SCHEMBL13401875 0.76 EGLN1 (0.50) EGLN1LDHAPLA2G2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103342696-B Substituted dihydropyrazolon for treating cardiovascular and haematological diseases BAYER SCHERING PHARMA AG 2015-03-11 CN disclosed
CN-103342696-A Substituted dihydropyrazolon for treating cardiovascular and haematological diseases BAYER HEALTHCARE AG 2013-10-09 CN disclosed
CN-101631785-B Substituted dihydropyrazolones for the treatment of cardiovascular and hematological disorders BAYER IP GMBH 2013-08-21 CN disclosed
CN-101631785-A Substituted dihydropyrazolones for the treatment of cardiovascular and hematological disorders BAYER SCHERING PHARMA AG 2010-01-20 CN disclosed
CN-101600710-A Bipyridyl dihydropyrazolone that replaces and their application BAYER HEALTHCARE AG (DE) 2009-12-09 CN disclosed
EP-0718290-B1 Carboxyalkyl heterocyclic derivatives NIPPON ZOKI PHARMACEUTICAL CO (JP) 2002-04-17 EP disclosed
US-5912261-A ANTIDIABETIC AGENTS NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 1999-06-15 US disclosed
EP-0718290-A1 Carboxyalkyl heterocyclic derivatives NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 1996-06-26 EP disclosed